Details for Patent: 7,541,363

✉ Email this page to a colleague

Which drugs does patent 7,541,363 protect, and when does it expire?

Patent 7,541,363 protects NOURIANZ and is included in one NDA.

This patent has fourteen patent family members in nine countries.

Summary for Patent: 7,541,363

Title:	Microcrystal
Abstract:	Microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,- 6-dione having an average particle size of less than 50 .mu.m; microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,- 6-dione having an average particle size of less than 50 .mu.m and a crystallinity of 20% or more or the like, which possess excellent solubility, stability, bioavailability, dispersing property in a pharmaceutical formulation; and the like are provided. A solid pharmaceutical formulation which is characterized by comprising the same is also provided.
Inventor(s):	Kuroda; Kazutoshi (Ichikawa, JP), Aoki; Noboru (Numazu, JP), Ochiai; Toshiro (Sunto-gun, JP), Uchida; Akihiro (Sunto-gun, JP), Ishikawa; Yasuhiro (Sunto-gun, JP), Kigoshi; Makoto (Sunto-gun, JP), Hayakawa; Eiji (Sunto-gun, JP), Asanome; Kazuki (Sunto-gun, JP)
Assignee:	Kyowa Hakko Kirin Co., Ltd. (Tokyo, JP)
Application Number:	10/554,511
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Device;

Drugs Protected by US Patent 7,541,363

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kyowa Kirin	NOURIANZ	istradefylline	TABLET;ORAL	022075-001	Aug 27, 2019		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
Kyowa Kirin	NOURIANZ	istradefylline	TABLET;ORAL	022075-002	Aug 27, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,541,363

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2003-131417	May 9, 2003

PCT Information
PCT Filed	May 07, 2004	PCT Application Number:	PCT/JP2004/006495
PCT Publication Date:	November 18, 2004	PCT Publication Number:	WO2004/099207

International Family Members for US Patent 7,541,363

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	546450	⤷ Sign Up
Australia	2004236101	⤷ Sign Up
Canada	2525037	⤷ Sign Up
China	100395245	⤷ Sign Up
China	1784405	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.